Status:

COMPLETED

Standalone Observational Study Assessing the Performance of an AI/ML Tech-based SaMD on Chest LDCT Images (REALITY)

Lead Sponsor:

Median Technologies

Conditions:

High Risk Cancer

Eligibility:

All Genders

50-80 years

Brief Summary

This is a Multinational, Multicenter, retrospective study for the evaluation of the standalone efficacy and safety of an Artificial Intelligence/Machine Learning (AI/ML) technology-based end-to-end Co...

Eligibility Criteria

Inclusion

  • ≥50-80 Years of age;
  • Current or ex-smoker (\>=20 pack years);
  • Patient screened and surveilled for lung cancer screening following lung cancer screening guidelines (equivalent to United States Preventive Services Task Force (USPSTF) 2021 Criteria);
  • Received LDCT due to inclusion in high-risk category for lung cancer.

Exclusion

  • Prior lung resection;
  • Pacemaker or other indwelling metallic medical devices in the thorax that interfere with CT acquisition;
  • Patients/images used during AI model development;
  • Patients with only hilar and/or mediastinal cancer(s);
  • Patients with only ground glass cancer(s);
  • Patients with nodules, solid or part-solid \>30mm (masses);
  • Patients that are not accompanied with the required clinical information;
  • Patients with imaging with any of the following: missing slices, slice thickness \>3mm;
  • Partial cover of the lung.

Key Trial Info

Start Date :

September 21 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 21 2024

Estimated Enrollment :

1147 Patients enrolled

Trial Details

Trial ID

NCT06576232

Start Date

September 21 2022

End Date

August 21 2024

Last Update

August 28 2024

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

University of Pennsylvania - Penn Center for Innovation

Philadelphia, Pennsylvania, United States, 19104

2

Baptist Clinical Research Institute

Memphis, Tennessee, United States, 38120

3

The University of Texas M.D. Anderson Cancer Center

Houston, Texas, United States, 77030

4

Fundacion instituto de investigacion sanitaria de la fundacion jimenez diaz (FJD)

Madrid, Spain, 28040